DEF 14A: NorthView Acquisition Corp. Seeks Extension to Complete Business Combination with Profusa

NorthView Acquisition Corp. is seeking stockholder approval to extend the deadline for completing a business combination by up to six months, aiming to finalize its merger with Profusa, Inc.

Summary

• NorthView Acquisition Corp. is holding an Annual Meeting of Stockholders on March 21, 2024, to vote on several proposals.
• The key proposal is to extend the date by which the company must complete a business combination from March 22, 2024, to as late as September 22, 2024.
• This extension requires amending the company's charter and its Investment Management Trust Agreement.
• The purpose of the extension is to allow more time to complete the proposed business combination with Profusa, Inc.
• Stockholders have the right to redeem their public shares for cash in connection with this extension.
• The estimated per-share redemption price is approximately $11.27 based on the current amount in the Trust Account.
• If the extension is not approved, the company will liquidate and distribute the Trust Account funds to public stockholders.
• The company is also asking stockholders to elect five directors and ratify the appointment of Marcum LLP as the independent auditor for the fiscal year ending December 31, 2024.
• Approval of the extension requires the affirmative vote of at least 65% of the outstanding shares of common stock.
• The Board of Directors recommends voting FOR all proposals.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the company needs an extension, the board expresses confidence in finding a business combination and recommends voting for the extension. However, there are risks associated with redemptions and potential liquidation.

Positives

• The extension provides stockholders with the opportunity to consider a business combination.
• Stockholders retain the right to vote on the business combination and redeem shares if the extension is implemented.
• The Board believes a business combination is in the best interests of stockholders.
• The company has already spent time, effort, and money on finding a business combination.

Negatives

• If the extension is not approved, the company will liquidate, and warrants will expire worthless.
• Redemption of shares could significantly reduce the amount in the Trust Account.
• There is no guarantee that a business combination will be completed even if the extension is approved.
• The per-share distribution from the Trust Account upon liquidation may be less than $10.10 plus interest due to unforeseen creditor claims.

Risks

• The amount remaining in the Trust Account may be significantly reduced due to redemptions.
• The company may need to obtain additional funds to complete a business combination, and there is no assurance that such funds will be available.
• The company may be deemed an investment company under the Investment Company Act of 1940, which could force liquidation.
• A 1% excise tax could be imposed on the Company in connection with redemptions.
• The proposed business combination may be subject to review by the Committee on Foreign Investment in the United States (CFIUS), which could block or delay the transaction.

Future Outlook

The company intends to hold another stockholder meeting prior to the Extended Date to seek approval of the business combination with Profusa. The company will remain a reporting company under the Exchange Act, and its common stock and public warrants will remain publicly traded.

Management Comments

• The Board believes that our stockholders should have an opportunity to consider a business combination.
• The Extension is intended to give our stockholders that opportunity, and to give the Company the opportunity to complete a business combination.

Industry Context

The document relates to a Special Purpose Acquisition Company (SPAC) seeking an extension to complete a merger, a common situation in the SPAC market due to regulatory hurdles and market conditions. Many SPACs have faced challenges in finding suitable targets and completing deals within the initial timeframe.

Comparison to Industry Standards

• The redemption rate and trust value are key metrics for SPACs.
• The document mentions a potential redemption price of approximately $11.27 per share, which is above the typical $10.00 NAV (Net Asset Value) seen in many SPACs, indicating potential interest or market confidence.
• Comparable companies include other SPACs that have sought extensions, such as those facing regulatory delays or difficulty in finalizing merger terms.
• The success of the extension and subsequent merger will depend on market conditions and investor sentiment, similar to other SPAC transactions.

Related Party Transactions

• In April 2021, the Sponsor paid $25,000 for Founder Shares.
• On April 27, 2023, the Company signed a Convertible Working Capital Promissory Note with the Sponsor for $1,200,000.
• Commencing on the effective date of the IPO, the Company began paying its Sponsor a total of $5,000 per month for administrative services; this agreement was terminated as of June 30, 2023.

Stakeholder Impact

• Stockholders have the opportunity to redeem their shares or participate in a potential business combination.
• If the extension is not approved, public stockholders will receive a pro rata share of the Trust Account upon liquidation.
• Sponsor, directors, and officers have a vested interest in the extension and business combination due to their ownership of Founder Shares and warrants.

Next Steps

• Stockholders vote on the extension proposal at the Annual Meeting on March 21, 2024.
• If approved, the company will file an amendment to the charter.
• The company will continue to work to consummate the business combination with Profusa by the Extended Date.
• Another stockholder meeting will be held to seek approval of the business combination.

Key Dates

Keywords

business combination, extension, redemption, Profusa, Trust Account, liquidation, stockholders, NorthView Acquisition Corp.